Novavax NVAX announced that the World Health Organization (“WHO”) has granted emergency use listing (“EUL”) to NVX-CoV2601, its updated protein-based COVID vaccine, for use in individuals aged 12 ...

Novavax Inc. could now get its Covid-19 vaccine to nearly 200 more countries. It’s a critical win in the company’s bid to get ...

Listen to this article Gaithersburg-based Novavax Inc. Tuesday announced its Nuvaxovid XBB.1.5 COVID-19 vaccine (NVX-CoV2601) ...

The emergency use listing is based on non-clinical data where the vaccine demonstrated immune responses against variants in ...

Erin Kissane, a co-founder of the COVID Tracking Project, rolled up her sleeve for the Novavax COVID-19 vaccine in ...

"The WHO Emergency Use Listing of our updated protein-based non-mRNA COVID-19 vaccine enables expedited regulatory approvals for its 194 member states and UN procurement agencies, such as UNICEF, ...

The new contest aims to spur innovation into longer “healthspans” with treatments that can actually reverse age-related ...

A lot has changed with COVID-19 vaccines since they first debuted back in December 2020. We’ve seen a few hit the market, one ...

The single-target vaccine is aimed at the XBB.1.5 Omicron subvariant of the coronavirus, which was dominant in the U.S. for ...

Shares of small biotech companies involved in CAR-T therapies plunged Tuesday as the FDA said it was investigating potential ...

Novavax announced that Nuvaxovid XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) has been granted Emergency Use Listing (EUL) by the ...

Erin Kissane, a co-founder of the COVID Tracking Project, rolled up her sleeve for the Novavax covid-19 vaccine in ...